skip to Main Content
An Overview of Current Workplace Drug Policies Across the United States

By Nathaniel M. Glasser and Anastasia A. Regne

As Cannabis Business Executive readers are undoubtedly aware, there is a growing acceptance of marijuana use throughout the United States. The numbers certainly speak for themselves. The 2017 National Survey on Drug Use and Health found that one in five adults in the United States have used marijuana, including 15% in the prior year, and 22.1% in the prior month – up from 20.8% in 2016.

Support for the legalization of cannabis continues to grow, too. In a 2018 Pew Research Center survey, 62% of U.S. respondents said that marijuana use should be legal, whereas only 31% supported legalization in 2000. State laws have responded to this trend: 33 states and Washington, D.C. have legalized medical marijuana; 10 states and Washington, D.C. allow both medical and recreational use of marijuana; and some states permit (limited) use of products with low levels of tetrahydrocannabinol (THC), while others permit only products containing cannabidiol (CBD). Some states, most recently New York and Hawaii, have also decriminalized the possession of small amounts of marijuana.

So – how does this support for cannabis impact employers’ drug screening policies?

What’s Required of a Workplace Drug Screening Policy

There is no comprehensive federal law that regulates drug testing in the private sector. The majority of states, however, have some sort of express regulation regarding drug screening, and employers must be sure to comply with the restrictions in each of the jurisdictions in which they operate. Employers who choose to drug test must first determine whether employees must be given notice of the intent to drug test.  12 states require a written policy and/or advance written notice of drug testing. In Minnesota, for instance, an employer that chooses to drug test must not only maintain a written drug testing policy, but must also test all applicants for the position subject to the drug screening. State laws also typically mandate who may conduct drug tests (usually only qualified testing labs), procedures after a positive test (such as whether the applicant/employee must be notified and/or given an opportunity to re-test), how the test results may be used by the employer (for example, for discipline or termination), and who pays for the test (typically the employer). 

State laws often regulate the time at which drug testing is permissible. Companies may want to test employees during the pre-employment screening process, after a workplace accident, when the company has reasonable suspicion to believe that an employee is intoxicated, or even randomly. But this is where employers should be most cautious – states vary as to the requirements and restrictions of employers’ drug testing practices. While pre-employment drug screening proliferates, employers should be aware that many states – including Alabama, Maine, Minnesota, Ohio, Oklahoma, Vermont, Washington, and the District of Columbia – prohibit such screening until a conditional offer of employment has been made to the applicants. 

In addition, employers must be careful to comply with state and local laws that govern cannabis use specifically.  For instance, New York City recently passed a law prohibiting pre-employment drug screening for cannabis or THC, and Nevada became the first state to bar employers from rejecting a job applicant because of a failed marijuana test.  Many other states, including Arizona, Arkansas, Connecticut, Delaware, Illinois, Maine, Minnesota, Oklahoma, Pennsylvania, Rhode Island, and West Virginia, expressly prohibit discrimination against certified medical marijuana users. New York mandates that employers have a duty to reasonably accommodate an employee who uses marijuana, and relies on an underlying health condition to justify the use. New Jersey’s high court just took up a case regarding the issue of reasonable accommodation, and may be the next state to impose such a requirement on employers.

While no federal law governing all drug testing in the private sector exists, the U.S. Department of Transportation (DOT) has comprehensive regulations covering transportation employers, safety-sensitive transportation employees, and service agents.  Employers covered by the DOT regulations may take adverse action against employees who test positive for cannabis, even if those employees live and work in states in which cannabis is legal.  Additionally, government contractors are covered by the federal Drug-Free Workplace Act of 1988, which requires contractors to agree to provide drug-free workplaces as a precondition of receiving a contract or grant from a federal agency, but which does not actually require the drug testing of applicants or employees. 

General Considerations

When designing or revamping drug testing policies, companies should be mindful not only of their legal obligations but also the impact on the talent pool. As acceptance of marijuana use and support for legalization continue to grow, companies that screen for marijuana should consider how testing will affect recruitment and retention efforts. Thus, companies should assess how they treat marijuana users, as well as whether and how their competitors utilize marijuana testing.

Beyond talent considerations, companies must consider whether to take a uniform or state-by-state approach to testing.  Fewer companies are enforcing zero tolerance policies. While some companies refuse to employ individuals who test positive for cannabis, many are choosing to accommodate use, even in states that do not require it. In such cases, employers should ask marijuana users about the frequency and time of use to determine whether it can effectively and safely be accommodated.  Where use appears to interfere with on-the-job performance, employers may consider imposing testing as part of a “last chance” agreement for an employee.

Best Practices

Given the patchwork of state and local drug testing laws, with the overlay of the federal prohibition against marijuana use and the DOT regulations, employers should carefully consider whether to implement jurisdiction-specific policies for each location in which they operate, or create a “one-size-fits-all” policy that complies with the most liberal drug testing laws. Once the design strategy has been decided, employers should consider the following best practices:

  • Drug testing practices should be applied consistently, especially if applicable law prohibits discrimination against certified medical marijuana users or requires accommodation.
  • If there is a duty to reasonably accommodate medical marijuana use, the employer first should engage in a fact-based inquiry to determine whether the individual is a permitted medical user. If the individual is a permitted user, the employer next should engage in the interactive process to determine whether medical marijuana use can be reasonably accommodated in the workplace. Note that some jurisdictions have stricter requirements than the interactive process; in New York City, for example, employers must engage in a “cooperative dialogue.”
  • Employers should provide notice and obtain consent from an applicant or employee prior to testing.
  • To ensure maximum compliance, drug testing should be conducted afterthe company provides a conditional job offer.Additionally, the screening should occur prior to the start date, so that any positive test can be addressed before the individual begins work.
  • If an employee drug test comes back positive, consider possible obligations under disability discrimination and medical marijuana laws.

Remember, no matter the law or policy, employers never need to accommodate all marijuana use.  First and foremost, employees cannot be impaired while on the job; thus, any marijuana use that causes an individual to be under the influence while at work does not need to be tolerated.  Additionally, most states still do not require accommodation for recreational users.


Nathaniel Glasser

Nathaniel Glasser

NATHANIEL M. GLASSER is a Member of the Firm in the Employment, Labor & Workforce Management practice, in the Washington, DC, office of Epstein Becker Green. His practice focuses on the representation of employers in employee relations and human resources compliance, as well as litigating claims of harassment, discrimination, whistleblowing, and wage-hour violations. He also advises clients on novel issues of employee relations, including drug testing and accommodation questions in the wake of new recreational and medical marijuana (cannabis) laws, as well as the implementation of artificial intelligence and predictive (or people) analytics in the workplace. He can be reached at (202)-861-1863 or [email protected]

ANASTASIA A. REGNE* is a Law Clerk – Admission Pending – in the Employment, Labor & Workforce Management practice, in the New York office of Epstein Becker Green. She will be focusing her practice on employment litigation, labor-management relations, and employment training, practices, and procedures, including: drug testing and accommodation questions, particularly concerning the interaction with new marijuana (cannabis) legislation.

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Cannabis Legalization and its Impact on the Transportation Industry

Trends in Cannabis Legalization While employers in the transportation industry are acutely aware of the effects COVID-19 has imposed over the last 18 months, another phenomenon has been making itself known: the ever-increasing tally of states and localities across the country legalizing cannabis for medicinal and recreational purposes. A majority of states now have enacted…

German Police’s Move To Stop Adult-Use Cannabis Legalisation A Throwback To Dark Days Of Prohibition

CALLS by the leaders of two German police unions for politicians to U-Turn on the their progressive march towards cannabis legalisation have been roundly condemned. This comes as political talks continue towards the the formation of a cannabis-friendly ‘Traffic-Light Coalition’. It appears that it is just these talks – and the potential for adult-use legalisation…

N.J. announces 14 new medical marijuana licenses, expanding market after long delay

New Jersey has licensed 14 new marijuana businesses, bringing a long-awaited expansion of the state’s medical marijuana program that exceeds original plans. The Cannabis Regulatory Commission on Friday announced the winners of a competitive and burdensome licensing process that began two years ago. Nearly 200 entrepreneurs applied for licenses to grow and sell medical marijuana,…

Cannabis tech startup Dutchie raises $350M to double valuation to $3.75B in less than a year

Dutchie is rolling in the green. The Bend, Ore.-based creators of technology to help facilitate legal cannabis orders has raised $350 million in a Series D funding round, announced Thursday. The influx of new cash comes just seven months after the startup raised $200 million. Dutchie’s valuation has doubled to $3.75 billion. “Cannabis presents opportunities…

More Categories

Back To Top
×Close search